Our Portfolio Companies
We invest in companies enabling the future of biotechnology, immunotherapy and life sciences.
RNA Splicing Analytics + Artificial Intelligence for Drug Discovery
Cancer and genetic diseases affect more than 30million people a year. Envisagenics' mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.
Acoustic Cell handling & BIOPROCESSING
FloDesign Sonics' Acoustic Separation Technology is unique, disruptive, and broad-based. FDS is set to disrupt bioprocessing and immunotherapy delivery, reducing cost and improving access to life-saving therapies, by enabling closed, automated, and gentle cell processing.